×

CNBC Healthy Returns

About

How innovators and investors are working with patients and providers to develop dynamic new solutions and create healthy returns.

CNBC presents a one-day event that brings together top health care investors, CEOs and technologists to explore the innovations that will drive better outcomes, financially and clinically.

Every health care company seeks to scale the best technology and develop profitable ways to cover the massive cost of research and development, investors are looking for actionable intelligence on who’s breaking through, and patients are hungry for affordable and effective care. Healthy Returns is a convening of leaders who are improving patient outcomes, maximizing innovation, building great new companies and reinventing incumbents.

Led by CNBC’s anchors and reporters and with input from a world-class advisory board, Healthy Returns will hone in on groundbreaking ideas that will transform the health care industry, cutting through the noise and weeding out the "sales pitch."

Attendees should expect to walk away with smart strategies and actionable insights from people who are shaping the industry, including:

Investment ideas and intelligence from the biggest and best health care hedge funds, venture capitalists and portfolio managers.

Strategic perspective from top health care CEOs.

• An early, inside look at groundbreaking, transformative innovations.

• Unique networking opportunities to connect with leaders in multiple disciplines – investors, executives, entrepreneurs and innovators.

Who should attend:

Health care investors, VCs, C-Suite executives from the biotech, pharma, health care and life sciences industries, health care IT BDMs.

Speakers

More speakers will be announced soon.

Tap or click a card to reveal more information:

Amy Abernethy
Amy Abernethy M.D., PhD, serves as chief medical officer, chief scientific officer and senior vice president, oncology of Flatiron Health.

READ MORE
Amy Abernethy M.D., PhD
Chief Medical Officer, Chief Scientific Officer, Senior Vice President, Flatiron Health
Bill George
Bill George is an American businessman and academic. He is professor of Management Practice and a Henry B. Arthur Fellow of Ethics, at Harvard Business School.

READ MORE
Bill George
Senior Fellow, Harvard Business School and Former Chairman and CEO, Medtronic
Scott Gottlieb
Dr. Gottlieb is the 23rd commissioner of the Food and Drug Administration.

READ MORE
Scott Gottlieb, M.D.
Commissioner of Food and Drugs, U.S. FDA
Fred Hassan
Fred Hassan is a special limited partner and managing director with the private equity firm, Warburg Pincus and chairman of Claret Group.

READ MORE
Fred Hassan
Special Limited Partner, Warburg Pincus and Chairman, Claret Group
John Noseworthy
Leonard S. Schleifer, M.D., PhD, is the founder, president and chief executive officer of Regeneron Pharmaceuticals.

READ MORE
Leonard S. Schleifer, M.D., PhD
Founder, President and CEO, Regeneron Pharmaceuticals
Agenda

Agenda coming soon

Advisory Board

 

Tap or click a card to reveal more information:

Amy Abernethy
Amy Abernethy M.D., PhD, serves as chief medical officer, chief scientific officer and senior vice president, oncology of Flatiron Health.

READ MORE
Amy Abernethy M.D., PhD
Chief Medical Officer, Chief Scientific Officer, Senior Vice President, Flatiron Health
Tony Coles
Dr. Coles is the chairman and chief executive officer of Yumanity Therapeutics, a biotechnology company. He also serves as chairman and chief executive officer of TRATE Enterprises LLC.

READ MORE
Tony Coles, M.D.
Chairman and CEO, Yumanity Therapeutics
Tony Coles
Dr. Cosgrove is president and chief executive officer of Cleveland Clinic, presiding over an $8 billion health-care system.

READ MORE
Delos M. Cosgrove, M.D.
President and CEO, Cleveland Clinic

Ken Davis
Dr. Kenneth L. Davis, is president and chief executive officer of the Mount Sinai Health System in New York City, one of the nation's largest integrated health systems.

READ MORE
Kenneth Davis, M.D.
President and CEO, Mount Sinai Health System
Sue Desmond Hellmann
Dr. Sue Desmond-Hellmann is a physician, scientist and philanthropist and is currently the chief executive officer of the Bill & Melinda Gates Foundation.

READ MORE
Sue Desmond-Hellmann
CEO, Bill & Melinda Gates Foundation
Esther Dyson
Esther Dyson is chairman of EDventure Holdings. Her primary activity is investing in and nurturing start-ups, with a recent focus on health care, human capital and aerospace.

READ MORE
Esther Dyson
Chairman, EDventure Holdings
Bill George
Bill George is an American businessman and academic. He is professor of Management Practice and a Henry B. Arthur Fellow of Ethics at Harvard Business School.

READ MORE
Bill George
Senior Fellow, Harvard Business School and Former Chairman and CEO, Medtronic
Dr. Laurie Glimcher
Dr. Laurie H. Glimcher, president and chief executive officer of Dana-Farber Cancer Institute, is also chief executive officer of Dana-Farber/Partners CancerCare.

READ MORE
Laurie Glimcher, M.D.
President and CEO, Dana-Farber Cancer Institute
Fred Hassan
Fred Hassan is a special limited partner and managing director with the private equity firm, Warburg Pincus and chairman of Claret Group.

READ MORE
Fred Hassan
Special Limited Partner, Warburg Pincus and Chairman, Claret Group
Jessica Mega
Jessica Mega is the chief medical officer of Verily. She is also a cardiologist who trained and practiced at Massachusetts General Hospital and Brigham and Women’s Hospital.

READ MORE
Jessica Mega, M.D., M.P.H
Chief Medical Officer, Verily
John Noseworthy
Dr. John H. Noseworthy is president and chief executive officer of Mayo Clinic.

READ MORE
John Noseworthy, M.D.
President and CEO, Mayo Clinic
Sean Parker
Sean Parker is the founder and president of The Parker Foundation. He helped to establish the Stand Up 2 Cancer and Cancer Research Institute's (CRI) Immunology Dream Team in 2012.

READ MORE
Sean Parker
Founder and President, The Parker Foundation
Eric Topol, M.D.
Eric Topol is the founder and director of the Scripps Translational Science Institute and professor of Molecular Medicine at the Scripps Research Institute.

READ MORE
Eric Topol, M.D.
Founder and Director, Scripps Translational Science Institute
Anne Wojcicki
Anne Wojcicki co-founded 23andMe in 2006 after a decade in health care investing focusing on biotechnology companies.

READ MORE
Anne Wojcicki
Co-Founder and CEO, 23andMe
Sponsors
FAQ

 

Are you looking for more information? Please contact the following: